Pregnane glycosides interfere with steroidogenic enzymes to down-regulate corticosteroid production in human adrenocortical H295R cells.
A group of bioactive steroidal glycosides (pregnanes) with anorectic activity in animals was isolated from several genera of milkweeds including Hoodia and Asclepias. In this study, we investigated the effects, structure-activity relationships, and mechanism of action of pregnane glycosides on steroidogenesis in human adrenocortical H295R cells. Administration of pregnane glycosides for 24 h suppressed the basal and forskolin-stimulated release of androstenedione, corticosterone, and cortisone from H295R cells. The conversion of progesterone to 11-deoxycorticosterone and 17-hydroxyprogesterone to either androstenedione or 11-deoxycortisol was most strongly affected, with 12-cinnamoyl-, benzoyl-, and tigloyl-containing pregnanes showing the highest activity. Incubation of pregnane glycosides for 24 h had no effect on mRNA transcripts of CYP11A1, CYP21A1, CYP11B1 cytochrome enzymes and steroidogenic acute regulatory protein (StaR) protein, yet resulted in twofold decrease in HSD3B1 mRNA levels. At the same time, pregnane glycosides had no effect on the CYP1, 2, or 3 drug and steroid metabolism enzymes and showed weak Na(+) /K(+) ATPase and glucocorticoid receptor binding. Taken together, these data suggest that pregnane glycosides specifically suppress steroidogenesis through strong inhibition of 11β-hydroxylase and steroid 17-alpha-monooxygenase, and weak inhibition of cytochrome P450 side chain cleavage enzyme and 21β-hydroxylase, but not 3β-hydroxysteroid dehydrogenase/isomerase.
Biotech Center, SEBS, Rutgers University, New Brunswick, NJ, USA. komarnytsky@ncsu.edu
Slavko
S
Komarnytsky
Debora
D
Esposito
Alexander
A
Poulev
Ilya
I
Raskin
D015096:3-Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D000305:Adrenal Cortex Hormones / Q000378:metabolism; D000735:Androstenedione / Q000031:analogs & derivatives; D000818:Animals; D045744:Cell Line, Tumor; D002786:Cholesterol Side-Chain Cleavage Enzyme / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D003345:Corticosterone / Q000096:biosynthesis / Q000378:metabolism; D003348:Cortisone / Q000378:metabolism; D006027:Glycosides / Q000008:administration & dosage*; D006801:Humans; D011278:Pregnanes / Q000008:administration & dosage*; D011374:Progesterone / Q000031:analogs & derivatives / Q000096:biosynthesis; D013252:Steroid 11-beta-Hydroxylase / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D013254:Steroid 17-alpha-Hydroxylase / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D013329:Structure-Activity Relationship
D000305:Adrenal Cortex Hormones; D006027:Glycosides; D011278:Pregnanes; C574437:pregnane glycoside; D000735:Androstenedione; D011374:Progesterone; D015096:3-Hydroxysteroid Dehydrogenases; D013254:Steroid 17-alpha-Hydroxylase; D013252:Steroid 11-beta-Hydroxylase; D002786:Cholesterol Side-Chain Cleavage Enzyme; D003348:Cortisone; D003345:Corticosterone